UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD)

The Annals of pharmacotherapy, 2014-02, Vol.48 (2), p.209-225

2014

Volltextzugriff (PDF)

Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks

Biological psychiatry (1969), 2011-06, Vol.69 (12), p.e89-e99

Arnsten, Amy F.T

2011

Volltextzugriff (PDF)

Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors

Journal of Neural Transmission, 2013-06, Vol.120 (6), p.893-902

2013

Volltextzugriff (PDF)

Propargylamine-derived multi-target directed ligands for Alzheimer’s disease therapy

Bioorganic & medicinal chemistry letters, 2020-02, Vol.30 (3), p.126880-126880, Article 126880

2020

Volltextzugriff (PDF)

Pharmacological and psychosocial treatments for adolescents with ADHD: An updated systematic review of the literature

Clinical psychology review, 2014-04, Vol.34 (3), p.218-232

2014

Volltextzugriff (PDF)

Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats

Psychopharmacology, 2012-01, Vol.219 (2), p.313-326

2012

Volltextzugriff (PDF)

Targeting impulsivity in Parkinson's disease using atomoxetine

Brain (London, England : 1878), 2014-07, Vol.137 (Pt 7), p.1986-1997

2014

Volltextzugriff (PDF)

Propargylamine as functional moiety in the design of multifunctional drugs for neurodegenerative disorders: MAO inhibition and beyond

Future medicinal chemistry, 2015-01, Vol.7 (5), p.609-629

2015

Volltextzugriff (PDF)

Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies

European neuropsychopharmacology, 2013-06, Vol.23 (6), p.508-527

2013

Volltextzugriff (PDF)

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes

The journal of clinical psychiatry, 2010-06, Vol.71 (6), p.754-763

2010

Volltextzugriff (PDF)

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

Neurology, 2010-08, Vol.75 (5), p.448-455

2010

Volltextzugriff (PDF)

The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety

Neuropharmacology, 2009-12, Vol.57 (7), p.608-618

2009

Volltextzugriff (PDF)

Management of refractory typical GERD symptoms

Nature reviews. Gastroenterology & hepatology, 2016-05, Vol.13 (5), p.281-294

2016

Volltextzugriff (PDF)

Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists

Psychopharmacology, 2012-01, Vol.219 (2), p.341-352

2012

Volltextzugriff (PDF)

Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord

Journal of neuroinflammation, 2018-06, Vol.15 (1), p.176-176, Article 176

2018

Volltextzugriff (PDF)

Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis

Scientific reports, 2021-10, Vol.11 (1), p.20827-17, Article 20827

2021

Volltextzugriff (PDF)

Urinary bladder sigma-1 receptors: A new target for cystitis treatment

Pharmacological research, 2020-05, Vol.155, p.104724, Article 104724

2020

Volltextzugriff (PDF)

Effects of Lesogaberan on Reflux and Lower Esophageal Sphincter Function in Patients With Gastroesophageal Reflux Disease

Gastroenterology (New York, N.Y. 1943), 2010-08, Vol.139 (2), p.409-417

2010

Volltextzugriff (PDF)

The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development

Molecular psychiatry, 2012-09, Vol.17 (9), p.946-954

2012

Volltextzugriff (PDF)

A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial

Gut, 2011-09, Vol.60 (9), p.1182-1188

2011

Volltextzugriff (PDF)

Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2 -Adrenergic and Dopamine D1 Receptors

Journal of the American Academy of Child and Adolescent Psychiatry, 2010-10, Vol.49 (10), p.1011-1023

2010

Volltextzugriff (PDF)

Meta-Analysis: Treatment of Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic Disorders

Journal of the American Academy of Child and Adolescent Psychiatry, 2009-09, Vol.48 (9), p.884-893

2009

Volltextzugriff (PDF)

Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys

Cerebral cortex (New York, N.Y. 1991), 2014-01, Vol.24 (1), p.174-185

2014

Volltextzugriff (PDF)

Pharmacological treatment of tic disorders and Tourette Syndrome

Neuropharmacology, 2013-05, Vol.68, p.143-149

2013

Volltextzugriff (PDF)

Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion

Journal of affective disorders, 2015-06, Vol.178, p.149-159

2015

Volltextzugriff (PDF)

1 – 25 von 1.586

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.264)
Mit Volltextzugriff
(825)

Publikationsform

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(1.423)
Propylamines - Therapeutic Use
(1.392)
Science & Technology
(964)
Life Sciences & Biomedicine
(957)
Male
(910)
Female
(782)
Atomoxetine Hydrochloride
(593)
Adult
(560)
Attention Deficit Disorder With Hyperactivity - Drug Therapy
(508)
Middle Aged
(502)
Child
(415)
Psychiatry
(386)
Adolescent
(384)
Adrenergic Uptake Inhibitors - Therapeutic Use
(367)
Pharmacology & Pharmacy
(345)
Aged
(320)
Propylamines - Adverse Effects
(303)
Biological And Medical Sciences
(288)
Medical Sciences
(287)
Animals
(265)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD)

Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks

Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors

Propargylamine-derived multi-target directed ligands for Alzheimer’s disease therapy

Pharmacological and psychosocial treatments for adolescents with ADHD: An updated systematic review of the literature

Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats

Targeting impulsivity in Parkinson's disease using atomoxetine

Propargylamine as functional moiety in the design of multifunctional drugs for neurodegenerative disorders: MAO inhibition and beyond

Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety

Management of refractory typical GERD symptoms

Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists

Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord

Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis

Urinary bladder sigma-1 receptors: A new target for cystitis treatment

Effects of Lesogaberan on Reflux and Lower Esophageal Sphincter Function in Patients With Gastroesophageal Reflux Disease

The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development

A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial

Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2 -Adrenergic and Dopamine D1 Receptors

Meta-Analysis: Treatment of Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic Disorders

Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys

Pharmacological treatment of tic disorders and Tourette Syndrome

Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion

Suchergebnisse filtern